1-20 of 23
Ravi Salgia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B045: The impact of smoking status on the genomic landscape of lung squamous cell carcinoma

Adam Rock, Sahil Garg, Ravi Salgia, Victoria Villaflor, Ramya Muddasani, Erminia Massarelli, Colby Jenkins
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (21_Supplement): B045.
https://doi.org/10.1158/1557-3265.LIQBIOP24-B045
Published: 13 November 2024
View article titled, Abstract B045: The impact of smoking status on the genomic landscape of lung squamous cell carcinoma
Journal Articles

Report of the First International Symposium on NUT Carcinoma

Christopher A. French, Michael L. Cheng, Glenn J. Hanna, Steven G. DuBois, Nicole G. Chau, Christine L. Hann, Simone Storck, Ravi Salgia, Matteo Trucco, Jennifer Tseng, Anastasios Stathis, Richard Piekarz, Ulrich M. Lauer, Christophe Massard, Kelly Bennett, Shodeinde Coker, Ulrike Tontsch-Grunt, Martin L. Sos, Sida Liao, Catherine J. Wu, Kornelia Polyak, Sarina A. Piha-Paul, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2493–2505.
https://doi.org/10.1158/1078-0432.CCR-22-0591
Published: 13 June 2022
View article titled, Report of the First International Symposium on NUT Carcinoma
Open the PDF for Report of the First International Symposium on NUT Carcinoma in another window
Journal Articles

AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer

Nellie K. McDaniel, Mari Iida, Kwangok P. Nickel, Colin A. Longhurst, Samantha R. Fischbach, Tamara S. Rodems, Carlene A. Kranjac, Amber Y. Bo, Qianyun Luo, Meghan M. Gallagher, Noah B. Welke, Kaitlyn R. Mitchell, Alison E. Schulz, Jaimee C. Eckers, Rong Hu, Ravi Salgia, Seungpyo Hong, Justine Y. Bruce, Randall J. Kimple, Deric L. Wheeler
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (16): 4349–4359.
https://doi.org/10.1158/1078-0432.CCR-19-3142
Published: 14 August 2020
View article titled, AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer
Open the PDF for AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, John P. Coan, Hannah E. Pearson, Harsh Bahrar, Tyler L. Fowler, Bryan P. Bednarz, Sandeep Saha, David Yang, Parkash S. Gill, Mark W. Lingen, Vassiliki Saloura, Victoria M. Villaflor, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (23): 6099.
https://doi.org/10.1158/1078-0432.CCR-18-3194
Published: 03 December 2018
View article titled, Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Open the PDF for Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma in another window
Journal Articles

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib

Primo N. Lara, Jr, Jeff Longmate, Philip C. Mack, Karen Kelly, Mark A. Socinski, Ravi Salgia, Barbara Gitlitz, Tianhong Li, Mariana Koczywas, Karen L. Reckamp, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4321–4326.
https://doi.org/10.1158/1078-0432.CCR-14-3281
Published: 30 September 2015
View article titled, Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib
Open the PDF for Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Who Previously Progressed on Erlotinib in another window
Journal Articles

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, John P. Coan, Hannah E. Pearson, Harsh Bahrar, Tyler L. Fowler, Bryan P. Bednarz, Sandeep Saha, David Yang, Parkash S. Gill, Mark W. Lingen, Vassiliki Saloura, Victoria M. Villaflor, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2601–2612.
https://doi.org/10.1158/1078-0432.CCR-14-2648
Published: 31 May 2015
View article titled, AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Open the PDF for AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

Michaela K. Keck, Zhixiang Zuo, Arun Khattri, Thomas P. Stricker, Christopher D. Brown, Matin Imanguli, Damian Rieke, Katharina Endhardt, Petra Fang, Johannes Brägelmann, Rebecca DeBoer, Mohamed El-Dinali, Serdal Aktolga, Zhengdeng Lei, Patrick Tan, Steve G. Rozen, Ravi Salgia, Ralph R. Weichselbaum, Mark W. Lingen, Michael D. Story, K. Kian Ang, Ezra E.W. Cohen, Kevin P. White, Everett E. Vokes, Tanguy Y. Seiwert
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4): 870–881.
https://doi.org/10.1158/1078-0432.CCR-14-2481
Published: 16 February 2015
View article titled, Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
Open the PDF for Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes in another window
Includes: Supplementary data
Journal Articles

Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic

Denis L.F. Jardim, Chad Tang, Debora De Melo Gagliato, Gerald S. Falchook, Kenneth Hess, Filip Janku, Siqing Fu, Jennifer J. Wheler, Ralph G. Zinner, Aung Naing, Apostolia M. Tsimberidou, Vijaykumar Holla, Marylin M. Li, Sinchita Roy-Chowdhuri, Raja Luthra, Ravi Salgia, Razelle Kurzrock, Funda Meric-Bernstam, David S. Hong
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6336–6345.
https://doi.org/10.1158/1078-0432.CCR-14-1293
Published: 14 December 2014
View article titled, Analysis of 1,115 Patients Tested for <em>MET</em> Amplification and Therapy Response in the MD Anderson Phase I Clinic
Open the PDF for Analysis of 1,115 Patients Tested for <em>MET</em> Amplification and Therapy Response in the MD Anderson Phase I Clinic in another window
Includes: Supplementary data
Journal Articles

Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies

Ravi Salgia, Premal Patel, John Bothos, Wei Yu, Steve Eppler, Priti Hegde, Shuang Bai, Surinder Kaur, Ihsan Nijem, Daniel V.T. Catenacci, Amy Peterson, Mark J. Ratain, Blase Polite, Janice M. Mehnert, Rebecca A. Moss
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1666–1675.
https://doi.org/10.1158/1078-0432.CCR-13-2070
Published: 13 March 2014
View article titled, Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
Open the PDF for Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies in another window
Includes: Supplementary data
Journal Articles

Abstract A24: Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.

Eunkyung An, Wei-Li Liao, Sheeno Thyparambil, Jaime Rodriguez, Ravi Salgia, Ignacio I. Wistuba, Jon Burrows, Todd Hembrough
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): A24.
https://doi.org/10.1158/1078-0432.14AACRIASLC-A24
Published: 16 January 2014
View article titled, Abstract A24: Development and clinical validation of a quantitative mass spectrometric assay for PD-L1 protein in FFPE NSCLC samples.
Journal Articles

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Mark A. Socinski, Jonathan Goldman, Iman El-Hariry, Marianna Koczywas, Vojo Vukovic, Leora Horn, Eugene Paschold, Ravi Salgia, Howard West, Lecia V. Sequist, Philip Bonomi, Julie Brahmer, Lin-Chi Chen, Alan Sandler, Chandra P. Belani, Timothy Webb, Harry Harper, Mark Huberman, Suresh Ramalingam, Kwok-Kin Wong, Florentina Teofilovici, Wei Guo, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 3068–3077.
https://doi.org/10.1158/1078-0432.CCR-12-3381
Published: 30 May 2013
View article titled, A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer
Open the PDF for A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A37: Interim analysis of CALGB 150607: A pilot study of the mutational & expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung adenocarcinoma specimens

Ravi Salgia, Vidya Nallasura, Robert A. Kratzke, Everett E. Vokes, Herbert Pang, Cleo E. Rolle, Rajani Kanteti, Rifat Hasina, William Richards, Lydia Hodgson, Qudsia Arif, Aliya N. Husain
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): A37.
https://doi.org/10.1158/1078-0432.12AACRIASLC-A37
Published: 01 February 2012
View article titled, Abstract A37: Interim analysis of CALGB 150607: A pilot study of the mutational &amp; expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung adenocarcinoma specimens
Open the PDF for Abstract A37: Interim analysis of CALGB 150607: A pilot study of the mutational & expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung adenocarcinoma specimens in another window
Journal Articles

Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer

Dylan M. Glubb, Elisa Cerri, Alexandra Giese, Wei Zhang, Osman Mirza, Emma E. Thompson, Peixian Chen, Soma Das, Jacek Jassem, Witold Rzyman, Mark W. Lingen, Ravi Salgia, Fred R. Hirsch, Rafal Dziadziuszko, Kurt Ballmer-Hofer, Federico Innocenti
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5257–5267.
https://doi.org/10.1158/1078-0432.CCR-11-0379
Published: 14 August 2011
View article titled, Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Open the PDF for Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells

Ana R. Jensen, Saito Y. David, Chuanhong Liao, Jinlu Dai, Evan T. Keller, Hikmat Al-Ahmadie, Kelly Dakin-Haché, Peter Usatyuk, Margarit F. Sievert, Gladell P. Paner, Soheil Yala, Gustavo M. Cervantes, Viswanathan Natarajan, Ravi Salgia, Edwin M. Posadas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3112–3122.
https://doi.org/10.1158/1078-0432.CCR-10-1264
Published: 15 May 2011
View article titled, Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells
Open the PDF for Fyn Is Downstream of the HGF/MET Signaling Axis and Affects Cellular Shape and Tropism in PC3 Cells in another window
Includes: Multimedia, Supplementary data
Journal Articles

Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

Soundararajan Krishnaswamy, Rajani Kanteti, Jonathan S. Duke-Cohan, Sivakumar Loganathan, Wanqing Liu, Patrick C. Ma, Martin Sattler, Patrick A. Singleton, Nithya Ramnath, Federico Innocenti, Dan L. Nicolae, Zheng Ouyang, Jie Liang, John Minna, Mark F. Kozloff, Mark K. Ferguson, Viswanathan Natarajan, Yi-Ching Wang, Joe G.N. Garcia, Everett E. Vokes, Ravi Salgia
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5714–5723.
https://doi.org/10.1158/1078-0432.CCR-09-0070
Published: 14 September 2009
View article titled, Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
Open the PDF for Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Concerted Potent Humoral Immune Responses to Autoantigens Are Associated with Tumor Destruction and Favorable Clinical Outcomes without Autoimmunity

Taylor Sittler, Jun Zhou, Joosang Park, Noah K. Yuen, Stefanie Sarantopoulos, Joseph Mollick, Ravi Salgia, Anita Giobbie-Hurder, Glenn Dranoff, F. Stephen Hodi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (12): 3896–3905.
https://doi.org/10.1158/1078-0432.CCR-07-4782
Published: 16 June 2008
View article titled, Concerted Potent Humoral Immune Responses to Autoantigens Are Associated with Tumor Destruction and Favorable Clinical Outcomes without Autoimmunity
Open the PDF for Concerted Potent Humoral Immune Responses to Autoantigens Are Associated with Tumor Destruction and Favorable Clinical Outcomes without Autoimmunity in another window
Journal Articles

c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma

Neelu Puri, Salman Ahmed, Varalakshmi Janamanchi, Maria Tretiakova, Osvaldo Zumba, Thomas Krausz, Ramasamy Jagadeeswaran, Ravi Salgia
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2246–2253.
https://doi.org/10.1158/1078-0432.CCR-06-0776
Published: 02 April 2007
View article titled, c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
Open the PDF for c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer

Tanguy Y. Seiwert, Philip P. Connell, Ann M. Mauer, Philip C. Hoffman, Christopher M. George, Livia Szeto, Ravi Salgia, Katherine E. Posther, Binh Nguyen, Daniel J. Haraf, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 515–522.
https://doi.org/10.1158/1078-0432.CCR-06-1058
Published: 25 January 2007
View article titled, A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer
Open the PDF for A Phase I Study of Pemetrexed, Carboplatin, and Concurrent Radiotherapy in Patients with Locally Advanced or Metastatic Non–Small Cell Lung or Esophageal Cancer in another window
Journal Articles

Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas

M. Kelly Nicholas, Rimas V. Lukas, Nazia F. Jafri, Leonardo Faoro, Ravi Salgia
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7261–7270.
https://doi.org/10.1158/1078-0432.CCR-06-0874
Published: 22 December 2006
View article titled, Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas
Open the PDF for Epidermal Growth Factor Receptor–Mediated Signal Transduction in the Development and Therapy of Gliomas in another window
Journal Articles

A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin

Patrick C. Ma, Erik Schaefer, James G. Christensen, Ravi Salgia
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2312–2319.
https://doi.org/10.1158/1078-0432.CCR-04-1708
Published: 23 March 2005
View article titled, A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin
Open the PDF for A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin in another window